LXRX : Summary for Lexicon Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets closed

Lexicon Pharmaceuticals, Inc. (LXRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.610.00 (0.00%)
At close: 4:00PM EDT
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close15.61
Bid13.02 x 200
Ask16.40 x 100
Day's Range15.46 - 15.74
52 Week Range11.52 - 19.62
Avg. Volume912,755
Market Cap1.63B
PE Ratio (TTM)-11.46
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire2 days ago

    Lexicon Pharmaceuticals To Host First Quarter 2017 Financial Results Conference Call And Webcast On May 2, 2017

    THE WOODLANDS, Texas, April 28, 2017 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (LXRX), will release its first quarter 2017 financial results on Tuesday, May 2, 2017 after market close. Management will conduct a conference call and live webcast at 6:00 pm EDT (5:00 pm CT) that day to discuss the financial results and to provide a corporate update.

  • Capital Cube4 days ago

    Lexicon Pharmaceuticals, Inc. – Value Analysis (NASDAQ:LXRX) : April 26, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Lexicon Pharmaceuticals, Inc. a score of 21. Our analysis is based on comparing Lexicon Pharmaceuticals, Inc. with the following peers – BioTime, Inc., Regeneron Pharmaceuticals, Inc., Ultragenyx Pharmaceutical, Inc., Illumina, Inc., Aerie Pharmaceuticals, Inc., Esperion Therapeutics, Inc., Ligand Pharmaceuticals Incorporated, Thermo Fisher Scientific Inc., BioMarin Pharmaceutical Inc. ... Read more (Read more...)

  • Capital Cube5 days ago

    ETFs with exposure to Lexicon Pharmaceuticals, Inc. : April 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Lexicon Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to LXRX-US. Comparing the performance and risk of Lexicon Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)